Andrew Burnett Joins ACLA as Director of Government Affairs
Washington D.C. October 21, 2021 – The American Clinical Laboratory Association (ACLA) today announced Andrew Burnett will join the Association as Director of Government Affairs helping to support and advance the industry’s key policy priorities on Capitol Hill.
“Andrew brings a wealth of legislative, regulatory and policy expertise that will support and build upon our mission to expand access to the vital clinical laboratory tests millions of Americans rely on,” said Tom Sparkman, ACLA’s Senior Vice President of Government Affairs and Policy. “His extensive knowledge of the Medicare and Medicaid programs as well as his clinical administration experience will be an asset as we work to move critical industry priorities forward, including preventing upcoming cuts to Medicare lab benefits and diagnostic reform.”
In his new position as Director of Government Affairs, Burnett will be responsible for advancing ACLA’s legislative and advocacy priorities in front of Congress, the Administration and other external stakeholders. Burnett brings years of experience advising, managing and driving policy initiatives for key leaders and stakeholders in the health care industry. Prior to this role, Burnett served as health policy advisor for Senator Richard Shelby (R-AL) and health research and policy assistant for the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) under Chairman Lamar Alexander (R-TN). Burnett also served as a clinic administrator for M.E.A. Medical Clinics in Ridgeland, Mississippi and as a financial coordinator at the University of Mississippi Medical Center, Blair E. Batson Children’s Hospital in Jackson, Mississippi.
Burnett received a bachelor’s degree in Business Administration and a master’s degree in Business Administration from the University of Mississippi.
The American Clinical Laboratory Association (ACLA) is the national trade association representing leading laboratories that deliver essential diagnostic health information to patients and providers. ACLA members are at the forefront of driving diagnostic innovation to meet the country’s evolving health care needs and provide vital clinical laboratory tests that identify and prevent infectious, acute and chronic disease. ACLA works to advance the next generation of health care delivery through policies that expand access to lifesaving testing services.